• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后并发症增加了术前肾功能正常的肾癌患者行保肾手术后发生长期慢性肾脏病的风险。

Postoperative complications increase the risk of long-term chronic kidney disease after nephron-sparing surgery in patients with renal cancer and normal preoperative renal function.

机构信息

Università Vita-Salute San Raffaele, Milan, Italy.

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.

出版信息

BJU Int. 2019 Sep;124(3):457-461. doi: 10.1111/bju.14712. Epub 2019 Mar 20.

DOI:10.1111/bju.14712
PMID:30768877
Abstract

OBJECTIVES

To investigate whether postoperative complications affect long-term functional outcomes of renal patients treated with nephron-sparing surgery (NSS).

MATERIALS AND METHODS

We performed an observational study, enrolling 596 patients with preoperative normal renal function treated with NSS for clinical T1abN0M0 renal masses. Cox regression models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for chronic kidney disease (CKD) including as covariates age, comorbidity (scored according to the Charlson comorbidity index), hypertension, tumour size, preoperative estimated glomerular filtration rate (eGFR), eGFR < 60 mL/min/1.73 m at discharge, and ischaemia time.

RESULTS

A total of 137 patients (23%) developed postoperative complications. At a median (interquartile range) follow-up of 53 (26-91) months, CKD risk was 19% for patients with postoperative complications and 11% for those without complications. Patients experiencing postoperative complications (HR 1.90, 95% CI 1.26-2.86) were at increased risk of developing CKD during the follow-up at multivariable analysis, after accounting for confounders.

CONCLUSIONS

Our data outline how postoperative complications might have a detrimental impact on postoperative renal function in patients submitted to NSS. Improper patient selection, increasing the risk of postoperative complications, could limit the benefit in terms of renal function brought by NSS.

摘要

目的

探讨肾部分切除术(NSS)治疗的肾患者术后并发症是否影响长期功能结局。

材料和方法

我们进行了一项观察性研究,共纳入 596 例术前肾功能正常、接受 NSS 治疗的临床 T1abN0M0 肾肿块患者。采用 Cox 回归模型估计慢性肾脏病(CKD)的风险比(HR)和 95%置信区间(CI),并将年龄、合并症(根据 Charlson 合并症指数评分)、高血压、肿瘤大小、术前估算肾小球滤过率(eGFR)、出院时 eGFR<60 mL/min/1.73 m2 和缺血时间作为协变量。

结果

共有 137 例(23%)患者发生术后并发症。在中位数(25%至 75%分位数)53(26-91)个月的随访中,术后并发症患者的 CKD 风险为 19%,无并发症患者的 CKD 风险为 11%。多变量分析显示,在考虑混杂因素后,发生术后并发症的患者(HR 1.90,95%CI 1.26-2.86)在随访期间发生 CKD 的风险增加。

结论

我们的数据概述了术后并发症如何对接受 NSS 治疗的患者的术后肾功能产生不利影响。患者选择不当,增加术后并发症的风险,可能会限制 NSS 在肾功能方面带来的益处。

相似文献

1
Postoperative complications increase the risk of long-term chronic kidney disease after nephron-sparing surgery in patients with renal cancer and normal preoperative renal function.术后并发症增加了术前肾功能正常的肾癌患者行保肾手术后发生长期慢性肾脏病的风险。
BJU Int. 2019 Sep;124(3):457-461. doi: 10.1111/bju.14712. Epub 2019 Mar 20.
2
Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively-maintained database.过去二十年来,肾肿瘤外科治疗的演变趋势:一项来自大型前瞻性数据库的现代研究。
Int J Urol. 2019 Apr;26(4):465-474. doi: 10.1111/iju.13909. Epub 2019 Feb 28.
3
Parenchymal Volumetric Assessment as a Predictive Tool to Determine Renal Function Benefit of Nephron-Sparing Surgery Compared with Radical Nephrectomy.实质体积评估作为一种预测工具,用于确定保留肾单位手术与根治性肾切除术相比对肾功能的益处。
J Endourol. 2016 Jan;30(1):114-21. doi: 10.1089/end.2015.0411. Epub 2015 Sep 25.
4
Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.保肾手术与根治性肾切除术对肾功能的影响:EORTC 随机试验 30904 的结果。
Eur Urol. 2014 Feb;65(2):372-7. doi: 10.1016/j.eururo.2013.06.044. Epub 2013 Jul 2.
5
End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline.肾功能正常患者肾手术后的终末期肾病:平衡手术策略和基线时的个体疾病。
Eur Urol. 2016 Oct;70(4):558-561. doi: 10.1016/j.eururo.2016.03.023. Epub 2016 Mar 25.
6
Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function.保肾技术独立于根治性肾切除术降低 T1a-T1b 期肾肿瘤和术前肾功能正常患者的心血管事件风险。
Eur Urol. 2015 Apr;67(4):683-9. doi: 10.1016/j.eururo.2014.09.027. Epub 2014 Oct 3.
7
Who really benefits from nephron-sparing surgery?肾保留手术真正使谁受益?
Urology. 2014 Oct;84(4):860-7. doi: 10.1016/j.urology.2014.05.061.
8
A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.机器人辅助部分肾切除术术后肾小球滤过率显著降低的预测列线图。
Eur Urol. 2018 Dec;74(6):833-839. doi: 10.1016/j.eururo.2018.08.037. Epub 2018 Sep 14.
9
Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer.缺血性和非缺血性腹腔镜与开放性肾部分切除术治疗肾细胞癌的肾功能结局。
BMC Nephrol. 2019 Feb 4;20(1):40. doi: 10.1186/s12882-019-1215-3.
10
Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial.静脉注射甘露醇与安慰剂在肾功能正常的部分肾切除术中的比较:一项双盲、临床整合、随机试验。
Eur Urol. 2018 Jan;73(1):53-59. doi: 10.1016/j.eururo.2017.07.038. Epub 2017 Aug 16.

引用本文的文献

1
Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.肾嗜酸细胞瘤:揭开肾癌“双重伪装”的诊断挑战。
Int J Mol Sci. 2022 Feb 26;23(5):2603. doi: 10.3390/ijms23052603.
2
The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now?循环生物标志物在转移性肾细胞癌肿瘤管理中的作用:我们目前的进展如何?
Biomedicines. 2021 Dec 31;10(1):90. doi: 10.3390/biomedicines10010090.
3
Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study.
T1N0M0期肾细胞癌幸存者的特定病因死亡率:一项基于登记处的队列研究
Front Oncol. 2021 Mar 10;11:604724. doi: 10.3389/fonc.2021.604724. eCollection 2021.